Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells

Peptides

Volumn 32, Issue 4, 2011, Pages 683-690

  Pérez Cordero, José Julián ^a   Lozano, José Manuel ^b   Cortés, Jimena ^c   Delgado, Gabriela ^a  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Antimicrobial peptides; Dendritic cells; Leishmania

Indexed keywords

CECROPIN A; CECROPIN B; CECROPIN P1; DERMASEPTIN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MELITTIN; NITRIC OXIDE; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN ANDROPIN; PROTEIN CLIP; PROTEIN PR 1; PROTEIN PR 2; PROTEIN PR 3; SYNTHETIC PEPTIDE; TACHYPLESIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; DRUG EFFICACY; GROWTH INHIBITION; HEMOLYSIS; HUMAN; HUMAN CELL; LEISHMANIA MAJOR; LEISHMANIA PANAMENSIS; LEISHMANIASIS; PRIORITY JOURNAL; PROMASTIGOTE;

AMINO ACID SEQUENCE; ANTIPROTOZOAL AGENTS; CULTURE MEDIA; CYTOKINES; DENDRITIC CELLS; HEMOLYSIS; HUMANS; LEISHMANIA; MOLECULAR SEQUENCE DATA; NITRIC OXIDE; PEPTIDES;

LEISHMANIA MAJOR; LEISHMANIA PANAMENSIS;

EID: 79952819338     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2011.01.011     Document Type: Article

References (58)

1. Aga E, Katschinski DM, van Zandbergen G, Laufs H, Hansen B, Muller K, et al. Inhibition of the spontaneous apoptosis of neutrophil granulocytes by the intracellular parasite Leishmania major. J Immunol 2002;169:898-905. (Pubitemid 34753446)
2. Akuffo H, Hultmark D, Engstom A, Frohlich D, Kimbrell D. Drosophila antibacterial protein, cecropin A, differentially affects non-bacterial organisms such as Leishmania in a manner different from other amphipathic peptides. Int J Mol Med 1998;1:77-82.
3. Aspedon A, Groisman EA. The antibacterial action of protamine: evidence for disruption of cytoplasmic membrane energization in Salmonella typhimurium. Microbiology 1996;142(Pt 12):3389-97. (Pubitemid 27026364)
4. Ault SK, Nicholls RS. [In process citation]. Biomedica 2010;30:159-3.
5. Baker MA, Maloy WL, Zasloff M, Jacob LS. Anticancer efficacy of Magainin2 and analogue peptides. Cancer Res 1993;53:3052-7.
6. Bogdan C, Rollinghoff M. The immune response to Leishmania: mechanisms of parasite control and evasion. Int J Parasitol 1998;28:121-34. (Pubitemid 28082065)
7. Bowdish DM, Davidson DJ, Scott MG, Hancock RE. Immunomodulatory activities of small host defense peptides. Antimicrob Agents Chemother 2005;49:1727-32. (Pubitemid 40631581)
8. Brandonisio O, Spinelli R, Pepe M. Dendritic cells in Leishmania infection. Microbes Infect 2004;6:1402-9. (Pubitemid 41110584)
9. Bryceson A. A policy for leishmaniasis with respect to the prevention and control of drug resistance. Trop Med Int Health 2001;6:928-34. (Pubitemid 33010880)
10. Chen FY, Lee MT, Huang HW. Evidence for membrane thinning effect as the mechanism for peptide-induced pore formation. Biophys J 2003;84:3751-8. (Pubitemid 36637870)
11. Chu-Kung AF, Nguyen R, Bozzelli KN, Tirrell M. Chain length dependence of antimicrobial peptide-fatty acid conjugate activity. J Colloid Interface Sci 2010;2:160-7.
12. Dathe M, Meyer J, Beyermann M, Maul B, Hoischen C, Bienert M. General aspects of peptide selectivity towards lipid bilayers and cell membranes studied by variation of the structural parameters of amphipathic helical model peptides. Biochim Biophys Acta 2002;1558:171-86. (Pubitemid 34075532)
13. De Lucca AJ, Walsh TJ. Antifungal peptides: novel therapeutic compounds against emerging pathogens. Antimicrob Agents Chemother 1999;43:1-11. (Pubitemid 29069190)
14. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 2004;27:305-18. (Pubitemid 38842803)
15. Diaz-Achirica P, Ubach J, Guinea A, Andreu D, Rivas L. The plasma membrane of Leishmania donovani promastigotes is the main target for CA(1-8)M(1-18), a synthetic cecropin A-melittin hybrid peptide. Biochem J 1998;330(Pt 1):453-60.
16. Ekengren S, Hultmark D. Drosophila cecropin as an antifungal agent. Insect Biochem Mol Biol 1999;29:965-72. (Pubitemid 29510663)
17. Escobar P, Milena Leal S, Herrera LV, Martinez JR, Stashenko E. Chemical composition and antiprotozoal activities of Colombian Lippia spp essential oils and their major components. Mem Inst Oswaldo Cruz 2010;105:184-90.
18. Fernandez-Reyes M, Diaz D, de la Torre BG, Cabrales-Rico A, Valles-Miret M, Jimenez-Barbero J, et al. Lysine N(epsilon)-trimethylation, a tool for improving the selectivity of antimicrobial peptides. J Med Chem 2010;53:5587-96.
19. Ganz T, Lehrer RI. Antimicrobial peptides of vertebrates. Curr Opin Immunol 1998;10:41-4. (Pubitemid 28112077)
20. Guerrero E, Saugar JM, Matsuzaki K, Rivas L. Role of positional hydrophobicity in the leishmanicidal activity of magainin 2. Antimicrob Agents Chemother 2004;48:2980-6. (Pubitemid 38989164)
21. Hamid R, Rotshteyn Y, Rabadi L, Parikh R, Bullock P. Comparison of alamar blue and MTT assays for high through-put screening. Toxicol In Vitro 2004;18:703-10. (Pubitemid 38900879)
22. Henao HH, Osorio Y, Saravia NG, Gomez A, Travi B. [Efficacy and toxicity of pentavalent antimonials (Glucantime and Pentostam) in an American cutaneous leishmaniasis animal model: luminometry application]. Biomedica 2004;24:393-402.
23. Hernandez AG, Payares G, Misle A, Dagger F. The heterogeneity of Leishmania cell-surface antigens. Parasitol Res 1989;75:583-8. (Pubitemid 19205857)
24. Hernandez C, Mor A, Dagger F, Nicolas P, Hernandez A, Benedetti EL, et al. Functional and structural damage in Leishmania mexicana exposed to the cationic peptide dermaseptin. Eur J Cell Biol 1992;59:414-24. (Pubitemid 23023052)
25. Hoskin DW, Ramamoorthy A. Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta 2008;1778:357-75.
26. Jenssen H, Hamill P, Hancock RE. Peptide antimicrobial agents. Clin Microbiol Rev 2006;19:491-511. (Pubitemid 44137212)
27. Kandler K, Shaykhiev R, Kleemann P, Klescz F, Lohoff M, Vogelmeier C, et al. The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands. Int Immunol 2006;18:1729-36. (Pubitemid 44884035)
28. Kondejewski LH, Jelokhani-Niaraki M, Farmer SW, Lix B, Kay CM, Sykes BD, et al. Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity. J Biol Chem 1999;274:13181-92.
29. Kropshofer H, Vogt AB, Hammerling GJ. Structural features of the invariant chain fragment CLIP controlling rapid release from HLA-DR molecules and inhibition of peptide binding. Proc Natl Acad Sci U S A 1995;92:8313-7.
30. Lai Y, Gallo RL. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol 2009;30:131-41.
31. Langham AA, Khandelia H, Kaznessis YN. How can a beta-sheet peptide be both a potent antimicrobial and harmfully toxic? Molecular dynamics simulations of protegrin-1 in micelles. Biopolymers 2006;84:219-31.
32. Lee C, McConnell HM. A general model of invariant chain association with class II major histocompatibility complex proteins. Proc Natl Acad Sci U S A 1995;92:8269-73.
33. Lesmes LP, Bohorquez MY, Carreno LF, Patarroyo ME, Lozano JM. A C-terminal cationic fragment derived from an arginine-rich peptide exhibits in vitro antibacterial and anti-plasmodial activities governed by its secondary structure properties. Peptides 2009;30:2150-60.
34. Lofgren SE, Miletti LC, Steindel M, Bachere E, Barracco MA. Trypanocidal and leishmanicidal activities of different antimicrobial peptides (AMPs) isolated from aquatic animals. Exp Parasitol 2008;118:197-202.
35. Luque-Ortega JR, Saugar JM, Chiva C, Andreu D, Rivas L. Identification of new leishmanicidal peptide lead structures by automated real-time monitoring of changes in intracellular ATP. Biochem J 2003;375:221-30. (Pubitemid 37255399)
36. Luque-Ortega JR, van't Hof W, Veerman EC, Saugar JM, Rivas L. Human antimicrobial peptide histatin 5 is a cell-penetrating peptide targeting mitochondrial ATP synthesis in Leishmania. FASEB J 2008;22:1817-28.
37. Marin M, Aguilar YA, Ramirez JR, Triana O, Muskus CE. [Molecular and immunological analyses suggest the absence of hydrophilic surface proteins in Leishmania (Viannia) panamensis]. Biomedica 2008;28:423-32.
38. Mason AJ, Marquette A, Bechinger B. Zwitterionic phospholipids and sterols modulate antimicrobial peptide-induced membrane destabilization. Biophys J 2007;93:4289-99. (Pubitemid 350294476)
39. McGwire BS, Kulkarni MM. Interactions of antimicrobial peptides with Leishmania and trypanosomes and their functional role in host parasitism. Exp Parasitol 2010;126:397-405.
40. Merrifield RB. New approaches to the chemical synthesis of peptides. Recent Prog Horm Res 1967;23:451-82.
41. Merrifield RB, Juvvadi P, Andreu D, Ubach J, Boman A, Boman HG. Retro and retroenantio analogs of cecropin-melittin hybrids. Proc Natl Acad Sci U S A 1995;92:3449-53.
42. Molhoek EM, den Hertog AL, de Vries AM, Nazmi K, Veerman EC, Hartgers FC, et al. Structure-function relationship of the human antimicrobial peptide LL-37 and LL-37 fragments in the modulation of TLR responses. Biol Chem 2009;390:295-303.
43. Mor A, Nguyen VH, Delfour A, Migliore-Samour D, Nicolas P. Isolation, amino acid sequence, and synthesis of dermaseptin, a novel antimicrobial peptide of amphibian skin. Biochemistry 1991;30:8824-30.
44. Mor A, Nicolas P. Isolation and structure of novel defensive peptides from frog skin. Eur J Biochem 1994;219:145-54. (Pubitemid 24053627)
45. Mukherjee S, Ukil A, Das PK. Immunomodulatory peptide from cystatin, a natural cysteine protease inhibitor, against leishmaniasis as a model macrophage disease. Antimicrob Agents Chemother 2007;51:1700-7. (Pubitemid 46744148)
46. Nakamura T, Furunaka H, Miyata T, Tokunaga F, Muta T, Iwanaga S, et al. Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus tridentatus). Isolation and chemical structure. J Biol Chem 1988;263:16709-13. (Pubitemid 18268849)
47. Oren Z, Hong J, Shai Y. A repertoire of novel antibacterial diastereomeric peptides with selective cytolytic activity. J Biol Chem 1997;272:14643-9. (Pubitemid 27251727)
48. Papermaster BW, Pincus JH, Lincoln P, Reisfeld RA. Probit analysis of cytotoxicity data. Transplantation 1974;18:541-4.
49. Pasupuleti M, Schmidtchen A, Chalupka A, Ringstad L, Malmsten M. End-tagging of ultra-short antimicrobial peptides by W/F stretches to facilitate bacterial killing. PLoS One 2009;4:e5285.
50. Prina E, Abdi SZ, Lebastard M, Perret E, Winter N, Antoine JC. Dendritic cells as host cells for the promastigote and amastigote stages of Leishmania amazonensis: the role of opsonins in parasite uptake and dendritic cell maturation. J Cell Sci 2004;117:315-25. (Pubitemid 38128909)
51. Ribeiro-Gomes FL, Otero AC, Gomes NA, Moniz-De-Souza MC, Cysne-Finkelstein L, Arnholdt AC, et al. Macrophage interactions with neutrophils regulate Leishmania major infection. J Immunol 2004;172: 4454-62. (Pubitemid 38375261)
52. Robledo SM, Puerta JA, Munoz DL, Guardo M, Velez ID. [Efficacy and tolerance of pentamidine for treatment of cutaneous leishmaniasis caused by por L (V) panamensis in Colombia]. Biomedica 2006;26(Suppl. 1): 188-93.
53. Samakovlis C, Kylsten P, Kimbrell DA, Engstrom A, Hultmark D. The andropin gene and its product, a male-specific antibacterial peptide in Drosophila melanogaster. EMBO J 1991;10:163-9. (Pubitemid 21905278)
54. Shai Y, Oren Z. From "carpet" mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides. Peptides 2001;22:1629-41.
55. Steiner H, Hultmark D, Engstrom A, Bennich H, Boman HG. Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature 1981;292:246-8. (Pubitemid 11001840)
56. Tuon FF, Amato VS, Graf ME, Siqueira AM, Nicodemo AC, Amato Neto V. Treatment of New World cutaneous leishmaniasis-a systematic review with a meta-analysis. Int J Dermatol 2008;47:109-24.
57. Von Stebut E. Immunology of cutaneous leishmaniasis: the role of mast cells, phagocytes and dendritic cells for protective immunity. Eur J Dermatol 2007;17:115-22. (Pubitemid 46456759)
58. Wang G, Li X, Wang Z. APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res 2009;37:D933-7.